Methods for exploring heterogeneity in meta-analysis

Evaluation and the Health Professions

Volumn 24, Issue 2, 2001, Pages 126-151

  Song, Fujian ^a   Sheldon, Trevor A ^b   Sutton, Alex J ^c   Abrams, Keith R ^c   Jones, David R ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DATA ANALYSIS; META ANALYSIS; METHODOLOGY; REVIEW; STATISTICS;

DATA INTERPRETATION, STATISTICAL; HUMANS; META-ANALYSIS; METHODS; PATIENT SELECTION;

EID: 0035177484     PISSN: 01632787     EISSN: None     Source Type: Journal    
DOI: 10.1177/01632780122034849     Document Type: Review

References (61)

1. Exploratory or analytic meta-analysis: Should we distinguish between them?
2. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems [CD-ROM]
3. The effectiveness of glucocorticoids in treating croup: Meta-analysis
4. The promise and problems of meta-analysis
5. Inter-study differences: How should they influence the interpretation and analysis of results?
6. Operating characteristics of a rank correlation test for publication bias
7. A random-effects regression model for meta-analysis
8. Advantage and limitations of meta-analytic regressions of clinical trials data
9. A comparison of statistical methods for combining event rates from clinical trials
10. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials
11. Classical methods of analysis of grouped data
12. Large trials vs. meta-analysis of smaller trials. How do their results compare?
13. Individual patient data meta-analyses in cancer
14. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
15. Meta-analysis: Beyond the grand mean?
16. Cholesterol lowering and mortality: The importance of considering initial level of risk
17. Meta-analysis in clinical trials
18. Resolving discrepancies between a meta-analysis and a subsequent large controlled trial
19. Trim and fill: A simple funnel plot based method of testing and adjusting for publication bias in meta-analysis
20. Bias in meta-analysis detected by a simple, graphical test
21. Heterogeneity and statistical significance in meta-analysis: An empirical study of 125 meta-analyses
22. A note on graphical presentation of estimated odds ratios from several clinical trials
23. Antidepressants for the depressed physically ill [CD-ROM]
24. Meta-analysis of second-line antirheumatic drugs: Sample size bias and uncertain benefit
25. Invited commentary: A critical look at some popular meta-analytic methods
26. Hypotheses and problems in research synthesis
27. Detecting and describing heterogeneity in meta-analysis
28. Fluoride varnishes (duraphat): A meta-analysis
29. Meta-analysis in clinical research
30. Summing up evidence: One answer is not always enough
31. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care
32. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
33. Accumulating evidence from independent studies: What we can win and what we can lose
34. Calcium antagonists for acute ischemic stroke [CD-ROM]
35. Identifying potentially interesting variables and analysis opportunities
36. The population risk as an explanatory variable in research synthesis of clinical trials
37. Uses of ecologic analysis in epidemiologic research
38. Diagnostic statistical procedures in medical meta-analyses
39. Evidence does not support link: Relation between hostility and coronary heart disease
40. A meta-analysis of thoracic radiotherapy for small-cell lung cancer
41. Artemether for severe malaria: A meta-analysis of randomized clinical trials
42. Random-effects meta-analyses are not always conservative
43. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis
44. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials
45. Exploring heterogeneity in randomized trials via meta-analysis
46. Letters to the editor. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials
47. The relation between treatment benefit and underlying risk in meta-analysis
48. Exploring heterogeneity in meta-analysis: Is the L'Abbé plot useful?
49. Publication and related biases
50. The potential and limitations of meta-analysis
51. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis
52. Misleading funnel plot for detection of bias in meta-analysis
53. Investigating underlying risk as a source of heterogeneity in meta-analysis
54. Why sources of heterogeneity in meta-analysis should be investigated
55. Letters to the editor: Investigating underlying risk as a source of heterogeneity in meta-analysis
56. Predictive ability of meta-analyses of randomized controlled
57. Variation in baseline risk as an explanation of heterogeneity in meta-analysis
58. The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer